Approval · Notice of Compliance 24246 · 2020
BIJUVA: Notice of Compliance 24246
Issued September 17, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24246
- Date
- September 17, 2020
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- PROGESTERONE 100 MG per CAP
- ESTRADIOL HEMIHYDRATE 0.5 MG per CAP
- ESTRADIOL HEMIHYDRATE 1 MG per CAP